Phase-Transition Probabilities: Lead vs Secondary Indications This chart shows the data from #msg-60339665 broken down by lead vs secondary indications. images.investorshub.advfn.com/images/uploads/2011/2/25/lrchidrug_dev_phase_transtn_probabilities_by_indctn.png Source: http://insidebioia.files.wordpress.com/2011/02/bio-ceo-biomedtracker-bio-study-handout-final-2-15-2011.pdf